Company Overview
CYTOSORBENTS CORP
CTSORevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-8M
2025 FY
Shares Outstanding
62M
2025 FY
EPS
-0.13USD
2025 FY
Company Information
SIC Code
3841
CIK Code
1175151
Exchange
Nasdaq
Location
US